Benzodiazepine receptor binding following chronic treatment with naloxone, morphine and met-enkephalin in normal rats

The effects of chronic administration of naloxone, morphine and met-enkephalin on benzodiazepine (BDZ) receptor binding in rat brain were determined 2 and 50 days after treatments were accomplished. Two days after naloxone treatment (75 micrograms/h s.c. for 14 days), enhanced BDZ receptor binding was observed in cingulate, frontal, piriform, entorhinal and sensorimotor cortices; amygdala complex, hippocampus, substantia nigra and central gray. Two days after morphine treatment (20 mg/kg i.p. daily for 6 days), increased BDZ receptor binding was detected in cingulate, frontal, piriform, entorhinal and sensorimotor cortices; amygdala complex, hippocampus and substantia nigra. Two days after met-enkephalin treatment (10 micrograms/h i.c.v. for 6 days) enhanced BDZ receptor binding was shown only in sensorimotor cortex. No significant changes were observed 50 days after the treatments were completed. These data indicate an important interaction between GABAergic and opioid peptide systems.

[1]  L. Hársing,et al.  Evidence for a gamma-aminobutyric acid (GABA) mediation in the benzodiazepine inhibition of the release of Met5-enkephalin elicited by depolarization. , 1982, The Journal of pharmacology and experimental therapeutics.

[2]  H. Johnston,et al.  Immunohistochemical evidence that Met-enkephalin and GABA coexist in some neurones in rat dorsal horn , 1992, Brain Research.

[3]  T. de Boer,et al.  Suppression of GABA-induced abstinence behaviour in naive rats by morphine and bicuculline. , 1977, Life sciences.

[4]  R. Olsen,et al.  Benzodiazepine/barbiturate/GABA receptor-chloride ionophore complex in a genetic model for generalized epilepsy. , 1986, Advances in neurology.

[5]  A. Kruszewska.  The role of GABA in morphine abstinence in rats. , 1988, Drug and alcohol dependence.

[6]  S. Snyder,et al.  Benzodiazepine recognition sites on GABA receptors , 1980, Nature.

[7]  T. Nabeshima,et al.  An Analysis of GABA Receptor Changes in the Discrete Regions of Mouse Brain After Acute and Chronic Treatments with Morphine , 1982, Journal of neurochemistry.

[8]  J. Engel,et al.  Effects of chronic naloxone pretreatment on amygdaloid kindling in rats , 1991, Epilepsy Research.

[9]  H. Fukuda,et al.  Stimulatory and protective effects of benzodiazepines on GABA receptors labeled with [3H]muscimol. , 1982, Life sciences.

[10]  R. Ritzmann,et al.  Differential down-regulation of delta opioid binding sites during physical dependence on methionine enkephalin in the rat. , 1989, Life sciences.

[11]  R. Macdonald,et al.  Barbiturate enhancement of GABA-mediated inhibition and activation of chloride ion conductance: correlation with anticonvulsant and anesthetic actions , 1981, Brain Research.

[12]  R. Racine,et al.  The effects of kindling on GABA-Mediated inhibition in the dentate gyrus of the rat. I. Paired-pulse depression , 1982, Brain Research.

[13]  F. Tortella,et al.  Characterization of opioid peptide-like anticonvulsant activity in rat cerebrospinal fluid , 1988, Brain Research.

[14]  A. Kastin,et al.  MIF-1 and Tyr-MIF-1 augment GABA-stimulated benzodiazepine receptor binding , 1987, Peptides.

[15]  I. Ho,et al.  Effects of acute and continuous morphine administration on the affinity of glutamic acid decarboxylase for pyridoxal 5'-phosphate. , 1979, Biochemical Pharmacology.

[16]  Chen Jianguo,et al.  A study on opioid peptides in CSF of patients with epilepsy , 1990, Epilepsy Research.

[17]  R. Squires,et al.  Non-stereospecific excitatory actions of morphine may be due to GABA-A receptor blockade. , 1987, European journal of pharmacology.

[18]  R. Olsen,et al.  Endogenous inhibitor of GABA binding in mammalian brain. , 1978, Life Science.

[19]  M. Amri,et al.  Effects of lingual nerve and chewing cortex stimulation upon activity of the swallowing neurons located in the region of the hypoglossal motor nucleus , 1991, Brain Research.

[20]  K. Shen,et al.  Opioids excite rather than inhibit sensory neurons after chronic opioid exposure of spinal cord-ganglion cultures , 1988, Brain Research.

[21]  N. Bowery,et al.  REVERSAL OF THE ACTION OF AMINO ACID ANTAGONISTS BY BARBITURATES AND OTHER HYPNOTIC DRUGS , 1978, British journal of pharmacology.

[22]  T. G. Smith,et al.  Naloxone antagonism of GABA-evoked membrane polarizations in cultured mouse spinal cord neurons , 1980, Brain Research.

[23]  K. Kuriyama,et al.  Possible involvement of GABA in morphine analgesia. , 1976, Biochemical pharmacology.

[24]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .

[25]  E. Kirkness,et al.  Phosphorylation of gamma-aminobutyrate (GABA)/benzodiazepine receptors by cyclic AMP-dependent protein kinase. , 1989, The Biochemical journal.

[26]  J. Engel,et al.  Interictal EEG spikes correlate with decreased, rather than increased, epileptogenicity in amygdaloid kindled rats , 1980, Brain Research.

[27]  R. Huganir,et al.  Functional modulation of GABAA receptors by cAMP-dependent protein phosphorylation. , 1992, Science.

[28]  R. Gutiérrez,et al.  Epileptogenesis and Muscular Hypertonic Postictal Phenomena Induced by Naloxone in Intact Cats , 1988, Epilepsia.

[29]  A. Kastin,et al.  Existence of antiopiate systems as illustrated by MIF-1/Tyr-MIF-1. , 1986, Life sciences.

[30]  H. Loh,et al.  Pharmacological manipulation of gamma-aminobutyric acid (GABA) in morphine analgesia, tolerance and physical dependence. , 1976, Life sciences.

[31]  J. Tallman,et al.  GABAergic modulation of benzodiazepine binding site sensitivity , 1978, Nature.

[32]  J. Skerritt,et al.  Enhancement of GABA binding by benzodiazepines and related anxiolytics. , 1983, European journal of pharmacology.

[33]  T. Nabeshima,et al.  Alterations of regional γ-aminobutyric acid receptors in morphine tolerant mice , 1981 .

[34]  R. Olsen,et al.  Protein kinase C and cAMP-dependent protein kinase phosphorylate the beta subunit of the purified gamma-aminobutyric acid A receptor. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Buckett.  Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine , 1980, Neuropharmacology.

[36]  L. Iversen,et al.  Evidence for naloxone and opiates as GABA antagonists [proceedings]. , 1976, British journal of pharmacology.

[37]  L L Iversen,et al.  Naloxone as a GABA antagonist: evidence from iontophoretic, receptor binding and convulsant studies. , 1978, European journal of pharmacology.

[38]  D. Greenblatt,et al.  Tyr-MIF-1 augments benzodiazepine receptor binding in vivo , 1987, Pharmacology Biochemistry and Behavior.

[39]  K. Shen,et al.  Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. , 1990, Trends in pharmacological sciences.

[40]  A. Guidotti,et al.  Cotransmitters: pharmacological implications. , 1983, Journal of neural transmission. Supplementum.

[41]  R. Olsen,et al.  Cyclic AMP‐Dependent Protein Kinase Decreases γ‐Aminobutyric AcidA Receptor‐Mediated 36Q1− Uptake by Brain Microsacs , 1991 .